By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ortho-McNeil-Janssen Pharmaceuticals, Inc. 

1125 Trenton-Harbourton Road

Titusville  New Jersey  08560  U.S.A.
Phone: 609-730-2000 Fax: 609-730-2323


SEARCH JOBS


Industry
Pharmaceutical






Company News
Johnson & Johnson (JNJ) Unit Ortho-McNeil-Janssen Pharmaceuticals, Inc. Ordered to Pay Record Breaking $327 Million Over Deceptive Risperdal Marketing Claims 6/6/2011 7:06:53 AM
Johnson & Johnson (JNJ)'s Ortho-McNeil-Janssen Pharmaceuticals, Inc. Neurologics Voluntarily Recalls Two Lots of TOPAMAX(R) 4/14/2011 10:57:45 AM
Receptos Announces License to Advance Structure-Based Drug Discovery for High-Value G-Protein Coupled Receptor (GPCR) Targets 1/6/2011 9:12:31 AM
Johnson & Johnson (JNJ)'s Ortho-McNeil-Janssen Pharmaceuticals, Inc. Dumps Arena Pharmaceuticals, Inc. (ARNA) Diabetes Drug, APD597 11/5/2010 8:05:38 AM
Anchor Therapeutics Announces Collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., Potential $480 Million in Milestones 9/9/2010 6:33:31 AM
Ortho-McNeil-Janssen Pharmaceuticals, Inc.'s Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain; Announces Positive Results 8/31/2010 8:13:48 AM
PriCaraâ„¢, Ortho-McNeil-Janssen Pharmaceuticals, Inc.: Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice 7/19/2010 8:21:30 AM
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT) 6/28/2010 8:29:56 AM
Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical AB on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to Develop Diabetes Therapy 6/23/2010 11:08:58 AM
Diamyd Medical AB Signs Agreement for Diabetes Therapy with Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Diamyd to Get $45 Million, and up to $580 Million 6/22/2010 6:36:29 AM
123
//-->